8x8 (EGHT)
(Real Time Quote from BATS)
$2.75 USD
+0.07 (2.61%)
Updated Dec 26, 2024 11:28 AM ET
1-Strong Buy of 5 1
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
EGHT 2.75 +0.07(2.61%)
Will EGHT be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for EGHT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EGHT
Samsara Up 53% in the Past 6 Months: Is the Stock Still a Screaming Buy?
Best Value Stocks to Buy for December 20th
EGHT: What are Zacks experts saying now?
Zacks Private Portfolio Services
8x8 (EGHT) Is Attractively Priced Despite Fast-paced Momentum
EGHT vs. SMAR: Which Stock Is the Better Value Option?
All You Need to Know About 8x8 (EGHT) Rating Upgrade to Strong Buy
Other News for EGHT
Nice remains favored name as Morgan Stanley highlights 2025 outlook for communication software stocks
8×8 price target raised to $2.60 from $2 at Morgan Stanley
8x8 price target raised by 60c at Morgan Stanley, here's why
Morgan Stanley Remains a Sell on 8X8 (EGHT)
A Glimpse Into The Expert Outlook On 8x8 Through 7 Analysts